Unified classification and risk-stratification in Acute Myeloid Leukemia.
Yanis Tazi,
Juan E Arango-Ossa,
Yangyu Zhou,
Elsa Bernard,
Ian Thomas,
Amanda Gilkes,
Sylvie Freeman,
Yoann Pradat,
Sean J Johnson,
Robert Hills,
Richard Dillon,
Max F Levine,
Daniel Leongamornlert,
Adam Butler,
Arnold Ganser,
Lars Bullinger,
Konstanze Döhner,
Oliver Ottmann,
Richard Adams,
Hartmut Döhner,
Peter J Campbell,
Alan K Burnett,
Michael Dennis,
Nigel H Russell,
Sean M Devlin,
Brian JP Huntly,
Elli Papaemmanuil
Sep 09, 2022
Clinical recommendations for Acute Myeloid Leukemia (AML) classification and risk-stratification remain heavily reliant on cytogenetic findings at diagnosis, which are present in <50% of patients. Using comprehensive molecular...